コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ients with CatC deficiency (Papillon-Lefevre syndrome).
2 (Diamond-Blackfan anemia, Shwachman-Diamond syndrome).
3 ory (Italy), causing the Olive Quick Decline Syndrome.
4 a female patient with estrogen insensitivity syndrome.
5 effects and its role in the cytokine release syndrome.
6 ents with COVID-19-related hyperinflammatory syndrome.
7 nsporter FLVCR2 have been reported in Fowler syndrome.
8 Frailty is a complex and prevalent clinical syndrome.
9 -molecule screen for fragile X tremor ataxia syndrome.
10 et the diagnostic criteria for more than one syndrome.
11 sease and 18 046 (56.1%) with acute coronary syndrome.
12 ocyte injury drives proteinuria or nephrotic syndrome.
13 questionnaire is widely used to assess this syndrome.
14 possible brain metabolic phenotypes of this syndrome.
15 sposition in patients with Shwachman-Diamond syndrome.
16 across the lifespan of individuals with Down syndrome.
17 ymorphic ventricular tachycardia and Brugada syndrome.
18 underaction of IO muscle and anti-elevation syndrome.
19 ith a history of physician-diagnosed Sjogren syndrome.
20 ractivity in a mouse model of Birt-Hogg-Dube syndrome.
21 constitutional inherited bone marrow failure syndrome.
22 of disease pathogenesis in this heritable HF syndrome.
23 thmogenic phenotypes associated with long-QT syndrome.
24 n podocytes to cellular damage and nephrotic syndrome.
25 ues, showing multidimensional adaptive trait syndromes.
26 study of patients with atypical parkinsonian syndromes.
27 ring SCAD among patients with acute coronary syndromes.
28 ths worldwide are caused by neurocardiogenic syndromes.
29 associated with known autosomal dominant OFC syndromes.
30 seemingly unrelated adult-onset inflammatory syndromes.
31 valuate deleterious DNMs in inherited cancer syndromes.
32 ragile X, Prader-Willi, Turner, and Williams syndromes.
36 1%), shock (31%), acute respiratory distress syndrome (25%), neurological events (25%), arrhythmias (
38 chanism has a crucial role in Birt-Hogg-Dube syndrome, a disorder that is caused by mutations in the
40 n related to Brown-Vialetto-Van Laere (BVVL) syndrome, a hereditary paediatric condition associating
41 pective multicenter cohort of acute coronary syndrome (ACS), in relation to BB use: prior to admissio
43 d diseases such as atypical hemolytic uremic syndrome (aHUS) and age-related macular degeneration.
45 , we first extracted data on myelodysplastic syndrome and acute myeloid leukaemia cases from Clinical
47 genes that determine different traits of the syndrome and are held together, because recombination be
48 kely to be contributing to the cause of this syndrome and consider how they might be modified or inhi
50 s with severe CRS may develop capillary leak syndrome and disseminated intravascular coagulation, wit
51 nsight into the disease mechanism of Wolfram syndrome and highlight new targets and drug candidates t
52 th versus without acute respiratory distress syndrome and in relation to complicated course, defined
53 tly associated with development of metabolic syndrome and insulin resistance, manifests when triglyce
54 mma during CpG-induced macrophage activation syndrome and is present at high levels in the circulatio
55 ciated with increased odds of acute coronary syndrome and its manifestations in individuals at high c
57 reated patients, grade >= 3 cytokine release syndrome and neurotoxicity occurred in 7% and 31%, respe
58 imination between acute respiratory distress syndrome and nonacute respiratory distress syndrome pati
60 cy at identifying multiple organ dysfunction syndrome and predicting new or progressive multiple orga
62 he prevalence of TKOS in sudden infant death syndrome and sudden unexplained death in the young is un
64 n of central nervous system lesions in Leigh syndrome and their biological evolution in view of their
65 ial fibrillation and a recent acute coronary syndrome and those undergoing percutaneous coronary inte
66 use of this outbreak of hantavirus pulmonary syndrome and to reconstruct person-to-person transmissio
68 With Atrial Fibrillation and Acute Coronary Syndrome and/or Percutaneous Coronary Intervention), pat
69 findings associated with Fregoli and Capgras syndromes and compare these with the proposed neural sub
70 ip between HTT repeat expansions and FTD/ALS syndromes and indicate that genetic screening of FTD/ALS
71 l damage (preeclampsia, eclampsia, and HELLP syndrome), and postoperative complications in patients u
72 sk of PAD events or VTE after acute coronary syndrome, and if such effects are related to levels of l
73 ort contributes to the pathogenesis of Barth syndrome, and more generally, showcases the utility of y
74 should be used for bronchiolitis obliterans syndrome; and the addition of newer treatment options fo
75 h can progress to acute respiratory distress syndrome (ARDS) in the most severe form, while children
76 air pollution on acute respiratory distress syndrome (ARDS) is limited, and most studies focus on AR
77 agonists in a rat acute respiratory distress syndrome (ARDS) model utilizing the PaO(2)/FiO(2)-ratio
78 nts who died from acute respiratory distress syndrome (ARDS) secondary to influenza A(H1N1) infection
85 e and treatment for leukaemia predisposition syndromes are scarce and recommendations are largely bas
88 ortant to note that we should consider PFAPA syndrome as a differential diagnosis when we meet with t
89 e methods in patients with neurodegenerative syndromes as referenced to neuropathologic findings.
91 rategies to treat individuals with metabolic syndrome, as RXR heterodimerizes with multiple nuclear r
96 ty, type 2 diabetes, hypertension, metabolic syndrome), but the mechanism underlying these associatio
100 c arrhythmias are long QT syndrome, short QT syndrome, catecholaminergic polymorphic ventricular tach
101 pe 1 (NF1) is a common cancer predisposition syndrome caused by mutations in the NF1 tumor suppressor
103 hemophagocytic lymphohistiocytosis is a rare syndrome characterized by immune dysregulation and hyper
105 have recently been associated with CAKUTHED syndrome, characterized by multiple congenital defects i
106 diatric Adolescent Acquired Immunodeficiency Syndrome Clinical Trials [IMPAACT] P1060); 183 age-match
107 nd magnetic resonance studies from our Leigh syndrome cohort to provide a detailed description of cen
108 ew or progressive multiple organ dysfunction syndrome, compared to the objective assessment of multip
110 enniality and annuality should be considered syndromes comprised of many interacting traits, and that
111 immunothrombosis in severe acute respiratory syndrome corona virus 2 pneumonia is linked to both acut
113 veys measuring anti-severe acute respiratory syndrome coronavirus 2 (anti-SARS-CoV-2) antibodies prov
114 ad 180,458 cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and 9,385 reported d
115 n a new pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and an existing pand
116 ce of antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the risk of subs
117 nd vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are being expedited
119 COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in China and
121 The rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has elicited an equa
123 past infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have many uses for p
124 vent infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an older populati
125 revious exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in populations, and
126 19) or detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the environment a
128 of introductions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) into Scotland using
129 Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is initiated by viru
132 ture.IMPORTANCE The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiological a
134 fective vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may be required to e
137 eliminary data from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia patients i
138 age, and sex and on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) prevalence and the c
139 or the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA in respiratory s
140 antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein, used
141 of airway cells by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that results in exce
142 earliest sustained severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission network
144 his pathogen, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causes a pathogenic
145 OVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in late 201
146 ission dynamics for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in order to inform
147 he causative agent, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a member of the
149 e disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsib
150 s who may carry the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), while striving to f
154 e to infection with severe acute respiratory syndrome coronavirus 2 during the coronavirus disease 20
155 sitive findings for severe acute respiratory syndrome coronavirus 2 from nasopharyngeal swab and cere
156 een associated with severe acute respiratory syndrome coronavirus 2 illness, but it remains unclear w
157 may be observed in severe acute respiratory syndrome coronavirus 2 infected patients, even in the ab
158 e 2019 out of 1,788 severe acute respiratory syndrome coronavirus 2 positive cases, rendering an over
159 ients infected with severe acute respiratory syndrome coronavirus 2 requiring venovenous extracorpore
160 and splatters), for severe acute respiratory syndrome coronavirus 2 transmission, has challenged care
161 chain reaction for severe acute respiratory syndrome coronavirus 2 was positive in 33.6%, whereas im
162 pandemic caused by severe acute respiratory syndrome coronavirus 2, resulting in significant morbidi
164 viruses, including severe acute respiratory syndrome coronavirus, human immunodeficiency virus 1, he
165 responses following severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection increase t
166 lls with SARS-CoV-2, Middle East respiratory syndrome CoV (MERS-CoV), bat CoV HKU5 expressing the SAR
167 old with confirmed severe acute respiratory syndrome-CoV-2 disease who were admitted to an ICU durin
171 ion for pediatric acute respiratory distress syndrome did not require the presence of bilateral infil
173 l deficits in the Ts65Dn mouse model of Down syndrome (DS), translation to human clinical trials to i
175 rging model of COVID-related cardiometabolic syndrome encompassing events before, during the acute ph
177 sions in England for types of acute coronary syndrome from Jan 1, 2019, to May 24, 2020, that were re
180 tors that are known to promote the metabolic syndrome generally cause pro-inflammatory alterations in
184 LHS/TGA" fetuses with hypoplastic left heart syndrome (HLHS) or transposition of the great arteries (
185 ere dengue hemorrhagic fever or dengue shock syndrome; however, the complexities of DENV immunopathog
186 flammatory diet is associated with metabolic syndrome, hypertension, abdominal obesity, and hypertrig
187 Mutations in CUBN cause Imerslund-Grasbeck syndrome (IGS), which is characterized by intestinal mal
192 hanges indicate the development of nephrotic syndrome in mice bearing the Asah1 podocyte-specific gen
193 nic variant in the gene associated with Lowe syndrome in one child, and an average of 1.8 reportable
196 ar blight, root rot, fruit rot and crown rot syndromes in squash (Cucurbita moschata), is a devastati
197 s with anemia and lower-risk myelodysplastic syndromes in whom erythropoiesis-stimulating agent thera
198 estigated the epidemiology of the "alpha-Gal syndrome" in the United States and sought additional evi
199 hogenesis in patients with obesity/metabolic syndrome, in which the GRK2-mediated signaling can be a
201 he 2002 outbreak of severe acute respiratory syndrome, including the system of cell entry, which is t
202 in patients with mutant IDH2 myelodysplastic syndromes, including in those who have had previous ther
203 ost, as is seen in the macrophage activation syndrome induced by severe infections, including in infe
204 endocrinopathy, enteropathy, X-linked (IPEX) syndrome is a lethal disease caused by mutations in a tr
205 loid-related proteinemia inflammatory (PAMI) syndrome is a novel genetic disorder, causing hypercalpr
206 oclonal gammopathy, and skin changes (POEMS) syndrome is a rare multisystem disease resulting from an
208 romeric Instability Facial Anomalies (ICF) 4 syndrome is a severe disease with increased mortality ca
211 an recognition of acute respiratory distress syndrome is associated with both systemic and respirator
213 Survival from acute respiratory distress syndrome is improving, and outcomes beyond mortality may
214 ation in exon 2.Since an adult case of PFAPA syndrome is likely to be made misunderstanding for infec
216 thogen that causes acquired immunodeficiency syndrome, is distinct from the more prevalent HIV-1 in s
217 significantly from that of Johanson-Blizzard syndrome (JBS), which is caused by bi-allelic variants i
220 ) more often agreed that living with Sjogren syndrome made every day a challenge (adjusted odds ratio
222 iologies, a range of other movement disorder syndromes may also present with SIBs, even though this c
224 ly ill patients with Middle East respiratory syndrome (MERS), accounting for time-varying confounders
225 ks of SARS-CoV-1 and Middle East respiratory syndrome (MERS), the development of therapeutic antibodi
228 te detection is challenging, as the clinical syndrome might be confused with either behavioural varia
231 er toevaluate the influence of the metabolic syndrome (MS) (obesity, hypertension, elevated triglycer
235 lammation, immunosuppression, and catabolism syndrome observed in adult human surgical sepsis survivo
236 T cell expansion characterized the HLH-like syndromes occurring in the murine model and in humans.
239 After excluding individuals with Marfan syndrome or bicuspid aortic valve, a family history of A
241 kaemia arising from previous myelodysplastic syndrome or myeloproliferative neoplasm, the presence of
242 en (12%) individuals had a diagnosis of Down syndrome or other developmental disorder, while 84 (52.5
243 piratory failure, acute respiratory distress syndrome, or multiple organ dysfunction; and direct tiss
244 y snoring through to obstructive sleep apnea syndrome (OSAS), may cause compromise of respiratory gas
245 meeting pediatric acute respiratory distress syndrome oxygenation criteria with bilateral infiltrates
246 ly unappreciated role in sHLH/cytokine storm syndrome pathogenesis by preventing macrophages from bec
247 s syndrome and nonacute respiratory distress syndrome patients (C-statistic, 0.78; 95% CI, 0.72-0.84)
250 d mucosal symptoms observed in many of these syndromes, patients are likely to present to an allergis
252 TEN) are diagnosed with PTEN hamartoma tumor syndrome (PHTS) and are at high risk for developing brea
254 increasing rates of complex hematologic pain syndromes, present in up to 60% of patients with maligna
255 actin cytoskeletal regulator Wiskott Aldrich syndrome protein (WASp) has been implicated in maintenan
257 pectrum of frontotemporal lobar degeneration syndromes provides a useful framework with which to unde
261 mmatory response to severe acute respiratory syndrome-related coronavirus 2 infection has a direct im
263 amage in murine models for Cornelia de Lange syndrome results in an inefficient and senescent placent
266 in inherited cardiac arrhythmias are long QT syndrome, short QT syndrome, catecholaminergic polymorph
268 bleeding; R: systemic inflammatory response syndrome (SIRS), spontaneous bacteria peritonitis (SBP),
269 of Alzheimer's disease will also localize to syndrome-specific and symptom-specific brain networks.
270 yocardial infarction or other acute coronary syndrome, stroke, or coronary revascularisation) per 1 m
271 the prevalence of complications of metabolic syndrome, such as non-alcoholic fatty liver disease.
272 rous neurological disorders and neurogenetic syndromes, such as autism spectrum disorder (ASD) and Dr
273 ssociated immune reconstitution inflammatory syndrome (TB-IRIS) when they commence antiretroviral the
275 ith a severe but heterogeneous developmental syndrome, termed syt1-associated neurodevelopmental diso
276 nt of neuromodulation therapies for Tourette syndrome that could use a closed-loop-based approach.
277 but, other than their association with Lynch syndrome, the contribution of genetic risk factors to UC
278 n its structure or function cause sick sinus syndrome, the most common reason for electronic pacemake
280 d Tomography in Patients With Acute Coronary Syndromes) trial (NCT02061891) evaluated the outcome of
284 gnitive impairment in participants with Down syndrome was classified with the Cambridge Cognitive Exa
285 olymphoid cancers develop in Wiskott-Aldrich syndrome (WAS), an X-linked primary immunodeficiency dis
286 Strategy to Medically Manage Acute Coronary Syndromes) was a double-blind, placebo-controlled random
287 he elastin gene (ELN) causes Williams-Beuren syndrome (WBS), while single nucleotide variants in ELN
291 ogical complications, such as Guillain-Barre syndrome, were reported(13,14) together with cases of mi
292 d help mitigate the development of metabolic syndrome where EAEP and AEP skim proteins could be poten
293 dds of developing acute respiratory distress syndrome, which increased by 62% (CI, 48% to 81%; P < 0.
296 Cdx2-transgenic mice develop myelodysplastic syndrome with progression to acute leukemia associated w
297 dy more than doubles the number of published syndromes with DNA methylation episignatures and, most s
298 r Blockers In Non-ST Elevated Acute Coronary Syndromes With Initial Invasive Indication [DUBIUS]; NCT
299 duced fungal pathogen that causes white-nose syndrome (WNS), survival of the species may ultimately d